Methadone withdrawal symptoms with nevirapine and efavirenz.
V
V
Pinzani
V
V
Faucherre
H
H
Peyriere
J P
JP
Blayac
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D003521:Cyclopropanes; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008691:Methadone / Q000009:adverse effects* / Q000493:pharmacokinetics; D009294:Narcotics / Q000009:adverse effects* / Q000493:pharmacokinetics; D019829:Nevirapine / Q000009:adverse effects*; D010078:Oxazines / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D009294:Narcotics; D010078:Oxazines; D019829:Nevirapine; C098320:efavirenz; D008691:Methadone